StocksFin Logo
CGEN logo
$CGEN

Compugen Ltd.

CGEN country of incorporation
|
https://cgen.com
|
Dr. Anat Cohen-Dayag
|
73 employees
NASDAQ | Healthcare | Biotechnology
CGEN reported its Q322 earnings on September 30, 2022 (109 weeks ago).
$0 -100% vs. Q321 Revenues Q322
0% -100% vs. Q321 Gross Profit Margin
0% 100% vs. Q321 Net Profit Margin
-23.04M ! 19.1% vs. Q321 Free Cash Flow Q322
$-0.14 ! -100% vs. Q321 EPS Q322
Company Card Q322
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
0
0
-11.75M
-21%
$-0.14
Q12022
0
0
-9.71M
$-0.11
FY2021
6M
 680k
-34.2M
$-0.41
Q42021
0
0
-8.65M
-40.4%
$-0.1
Q32021
6M
680k
-6.16M
+35.2%
$-0.07
Q22021
0
0
-9.5M
+4.1%
$-0.11
Q12021
0
0
-9.91M
$-0.12
FY2020
2M
 60k
-29.7M
$-0.37
FY2019
0
 0
-27.34M
$-0.43
FY2018
17.8M
 1.03M
-22.6M
$-0.41
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
99.37M
 19.55M
0
1.98M
79.82M
Q12022
120.93M
 22.78M
0
2.54M
98.15M
FY2021
132.16M
 25.47M
7.8M
3.52M
106.69M
FY2020
138.32M
 18.53M
7.14M
3.81M
119.78M
FY2019
53.76M
 15.44M
9.19M
4.18M
38.32M
FY2018
53.18M
 15.94M
5.86M
0
37.24M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY 2021
-22.75M
 6.62M
16.84M
-292k
-23.04M
FY2020
-28.32M
 -82.17M
108.46M
-166k
-28.49M
FY2019
-27.89M
 5.33M
25.93M
-155k
-28.04M
FY2018
-13.29M
 -35.16M
28.4M
-158k
-13.45M
FY2017
-30.66M
 46.28M
201k
-385k
-31.04M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees
Data not available.